CBER Biologics Effectiveness and Safety (BEST) (2020) | Federal Compass

Free Market Report: Trends & Observations
CBER Biologics Effectiveness and Safety (BEST) (2020)


Prepare yourself for competition by understanding federal market trends. Is this the right pursuit for my organization? How is the government buying my product and services? Is there an upcoming recompete for future work?


Contracting Agency/Office
Health and Human Services » Food and Drug Administration » FDA - Office of Operations » Office of Finance, Budget, Acquisitions, and Planning
NAICS
518210 Data Processing, Hosting, and Related Services
Competition Set-Aside Type
NONE

Award Type
IDC
Award Date
09/29/2020
Expiration Date
09/28/2025
No. of Awards
3
No. of Offers
4

Obligations by Fiscal Year

prime obligations by fiscal year

Download the Full Report Today
Trends & Observations: CBER Biologics Effectiveness and Safety (BEST) (2020)

The full contract vehicle assessment includes:
Preference Program Trends
Set Aside Preference
Key Buyers
Buying Trends & Activity
Funding Account Health
Task Order Activity
Small Business Trends
Contractor Performance
Potential Recompete Opportunities

If you do business with the Federal Government, you need Federal Compass.

We are a public sector market intelligence and solutions platform for government contracting.

Contracting Resources